Characteristics and conflicts of interest at Food and Drug Administration Gastrointestinal Drug Advisory Committee meetings.
<h4>Introduction</h4>The United States Food and Drug Administration (FDA) Gastrointestinal Drug Advisory Committee (GIDAC) is involved in gastrointestinal drug application reviews. Characteristics and conflicts of interest (COI) in GIDAC meetings are not well described. This study analyz...
Guardado en:
Autores principales: | Rishad Khan, Karam Elsolh, Nikko Gimpaya, Michael A Scaffidi, Rishi Bansal, Samir C Grover |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f4fba966226b48adb7a4e44f6e42689c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Automated detection of cecal intubation with variable bowel preparation using a deep convolutional neural network
por: Daniel J. Low, et al.
Publicado: (2021) -
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.
por: Kristin Rising, et al.
Publicado: (2008) -
Evaluation of an advisory committee as a model for patient engagement
por: Cynthia Kendell, et al.
Publicado: (2014) -
Meeting of the Advisory Committee of the Caribbean Planners Network (CPN)
Publicado: (2014) -
Screening and Identification of Lujo Virus Entry Inhibitors From an Food and Drug Administration-Approved Drugs Library
por: Junyuan Cao, et al.
Publicado: (2021)